4-Chloro-5-(2-ethylpyrrol-1-yl)-1-[2-(4-methylpiperazin-1-yl)ethyl]-3-phenylpyrazolo[3,4-c]pyridazine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4-Chloro-5-(2-ethylpyrrol-1-yl)-1-[2-(4-methylpiperazin-1-yl)ethyl]-3-phenylpyrazolo[3,4-c]pyridazine
• 英文别名: 4-chloro-5-(2-ethylpyrrol-1-yl)-1-[2-(4-methylpiperazin-1-yl)ethyl]-3-phenylpyrazolo[3,4-c]pyridazine
• 化学式: C₂₄H₂₈ClN₇
• 分子量: 450.0
• InChiKey: MTYYHKIICWECBH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  32
• 可旋转键数：
  6
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  55
• 氢给体数：
  0
• 氢受体数：
  5

文献信息

• PYRAZOLOPYRIDAZINES AND METHODS FOR TREATING RETINAL-DEGENERATIVE DISEASES AND HEARING LOSS ASSOCIATED WITH USHER SYNDROME
  申请人：Usher III Initiative

  公开号：US20140121197A1

  公开（公告）日：2014-05-01

  Compounds, compositions and methods for the treatment of retinal degenerative diseases, such as retinitis pigmentosa, Leber's congenital Amaurosis, Syndromic retinal degenerations, age-related macular degeneration and Usher Syndrome, and hearing loss associated with Usher Syndrome are described herein.

  本文描述了用于治疗视网膜退行性疾病（如视网膜色素变性症、勒伯先天性失明、综合性视网膜退行、老年性黄斑变性和阿什尔综合征）以及与阿什尔综合征相关的听力损失的化合物、组合物和方法。
• [EN] TREATMENT OF CANCER, INFLAMMATORY DISEASES AND AUTOIMMUNE DISEASES<br/>[FR] TRAITEMENT DU CANCER, DE MALADIES INFLAMMATOIRES ET DE MALADIES AUTO-IMMUNES
  申请人：USHER III INITIATIVE INC

  公开号：WO2022011091A1

  公开（公告）日：2022-01-13

  The present disclosure relates to methods for the treatment or prevention of cancer, an inflammatory disease or an autoimmune disease with compounds of the invention as disclosed herein. The present disclosure also relates to methods for reducing risk of developing cancer, an inflammatory disease or an autoimmune disease with compounds of the invention as disclosed herein.

  本公开涉及使用本文所披露的化合物治疗或预防癌症、炎症性疾病或自身免疫疾病的方法。本公开还涉及使用本文所披露的化合物降低患癌症、炎症性疾病或自身免疫疾病风险的方法。
• METHODS OF TREATING OR PREVENTING A PROTEOPATHY
  申请人：Usher III Initiative, Inc.

  公开号：US20180099974A1

  公开（公告）日：2018-04-12

  Methods for the treatment or prevention of a proteopathy are described herein.
• US9227976B2
  申请人：——

  公开号：US9227976B2

  公开（公告）日：2016-01-05
• US9371332B2
  申请人：——

  公开号：US9371332B2

  公开（公告）日：2016-06-21